Treatment effects (fluticasone propionate v placebo)
| Outcome variable | Point estimate | 95% CI | p value |
|---|---|---|---|
| FEV1=forced expiratory volume in 1 second; FVC=forced vital capacity; MEF25, MEF50=maximal expiratory flow at 25% and 50% of FVC; PC20=concentration provoking a fall in FEV1 of 20% or more. | |||
| FEV1 after | 0.250 | 0.113 to 0.386 | 0.0011 |
| FEV1 before | 0.218 | 0.038 to 0.398 | 0.0202 |
| FEV1 (% pred) after | 7.92 | 3.34 to 12.51 | 0.0018 |
| FEV1 (% pred) before | 6.81 | 0.86 to 12.75 | 0.0269 |
| MEF25 | 7.36 | 2.15 to 12.58 | 0.0080 |
| MEF50 | 7.54 | 3.10 to 11.97 | 0.0020 |
| FEV/FVC | 5.34 | 0.77 to 9.91 | 0.0243 |
| log2 PC20 | 0.872 | –0.891 to 2.64 | 0.3143 |